S100A9 and congenital bilateral aplasia of vas deferens from CFTR mutation: Notably, results based on three GEO datasets demonstrated that these two genes (S100A8 and S100A9) might also act as accurate biomarkers for patients with CAVD based on the ROC (receiver-operating characteristic) curve.